DNA polymorphisms of the apolipoprotein B gene (XbaI, EcoRI, and MspI RFLPs) in Norwegians at risk of atherosclerosis and healthy controls

Acta Cardiologica

Volumn 54, Issue 4, 1999, Pages 215-225

  Delghandi, Madjid ^a   Thangarajah, Rajikala ^a   Nilsen, Marit ^a   Grimsgaard, Sameline ^a   Bønaa, Kaare H ^a   Tonstad, Serena ^b   Jørgensen, Leif ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; ARGININE; CHOLESTEROL; GLUTAMIC ACID; GLUTAMINE; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; LYSINE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NORWAY; RECEPTOR BINDING; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0032848315     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Getz GS. An overview of atherosclerosis: a look to the future. Toxicologic Pathology 1990; 18: 81-86.
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
3. Lusis AJ. Genetic factors affecting blood lipoproteins: the candidate gene approach. J Lipid Res 1988; 29: 397-429.
4. Breslow JL. Apolipoprotein genetic variation and human diseuse. Physiol Rev 1988; 68: 85-132.
5. Breslow JL. Genetic basis of lipoprotein disorders. J Clin Invest 1989; 84: 373-380.
6. Goldstein JL, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease. 6th ed. McGraw-Hill, New York, 1989; 1215-1250.
7. Leren TP, Tonstad S, Gundersen KE, Bakken KS, Rodnmgen OK, Sundvold H, Ose L, Berg K. Molecular genetics of familial hypercholesterolemia in Norway. J Int Medicine 1997; 241: 185-194.
8. Leren TP, Solberg K, Rødningen OK, Tonstad S, Ose L. Two founder mutations in the LDL receptor gene in Norwegian familial hypercholesterolemia subjects. Atherosclerosis 1994; 111: 175-182.
9. Berg K. Lp(a) lipoprotein: An important genetic risk factor for atherosclerosis. Monographs in Human Genetics 1992; 14: 189-207.
10. Humphries SE, Dunning A, Xu CF, Peacock R, Talmud P, Hamsten A. DNA polymorphism studies. Approaches to elucidating multifactorial ischaemic heart disease: the apo B gene as an example. Annals of Medicine 1992; 24: 349-356.
11. Bøhn M, Bakken A, Erikssen J, Berg K. Xbal polymorphism in DNA at the apolipoprotein B locus is associated with myocardial infarction (MI). Clin Genet 1993; 44: 241-248.
12. Young SG. Recent progress in understanding apolipoprotein B. Circulation 1990; 82: 1574-1594.
13. Chan L. Apolipoprotein B, the major protein component of triglyceride-rich and low density lipoproteins. J Biol Chem 1992; 267: 25621-25630.
14. Priestly L, Knott T, Wallis S, Powell L, Pease R, Scott J. RFLP for the human apolipoprotein B gene. II. EcoRI. Nucleic Acids Res 1985; 13: 6790.
15. Priestly L, Knott T, Wallis S, Powell L, Pease R, Scott J. RFLP for the human apolipoprotein B gene. III. EcoRV. Nucleic Acids Res 1985; 13: 6791.
16. Priestly L, Knott T, Wallis S, Powell L, Pease R, Scott J. RFLP for the human apolipoprotein B gene. IV. MspI. Nucleic Acids Res 1985; 13: 6792.
17. Priestly L, Knott T, Wallis S, Powell L, Pease R, Brunt H, Scott J. RFLP for the human apolipoprotein B gene. V. XbaI. Nucleic Acids Res 1985; 13: 6793.
18. Priestly L, Knott T, Wallis S, Powell L, Pease R, Simon A, Scott J. RFLP for the human apolipoprotein B gene. I. BamMl. Nucleic Acids Res 1985; 13: 6789.
19. Darnfors C, Nilsson J, Protter AA, Carlson P, Talmud PJ, Humphries SE, Whalstrom J, Wiklund O, Bjursell G. RFLPs for the human apolipoprotein B gene HincIl and PvuIl. Nucleic Acids Res 1986; 14: 7153.
20. Boerwinkle E, Lee SS, Butler R, Schumaker VN, Chan L. Rapid typing of apolipoprotein B DNA polymorphisms by DNA amplification. Atherosclerosis 1990; 81: 225.
21. Blackhart BD, Ludwig EM, Pierotti VR, Caiati L, Onasch MA, Wallis SC, Powell L, Pease R, Knott TJ, Chu ML et al. Structure of human apolipoprotein B gene. J Biol Chem 1986; 261: 15364-15367.
22. Huang L-S, De Graaf J, Breslow JL. Apo B gene MspI RFLP in cxon 26 changes amino acid 3611 from Arg to Gln. J Lipid Res 1988; 29: 63-67.
23. Rajput-Williams J, Knott TJ, Wallis SC, Sweetnam P, Yarnell J, Cox N. Variation of apolipoprotein-B gene is associated with obesity, high blood cholesterol levels, and increased risk of coronary heart disease. Lancet 1988; ii: 1442-1446.
24. De Benedictis G, Rose G, Mazzei R, Leone O, Crescibene L, Brancati C, Carotenuto L. EcoRI-RFLP of the apo B gene: a study in a sample group from South Italy. Ann Hum Genet 1991; 55: 103-113.
25. Berg K, Powell LM, Wallis SC, Pease R, Knott TJ, Scott J. Genetic linkage between the antigenic group (Ag) variation and the apolipoprotein B gene: assignment of the Ag locus. Proc Natl Acad Sci USA 1986; 83: 7367-7370.
26. Hegele RA, Huang LS, Herbert PN, Blum CB, Buring JE, Hennekens CH, Breslow JL. Apolipoprotein B gene DNA polymorphisms associated with myocardial infarction. N Engl J Med 1986; 315: 1509-1515.
27. Genest JJ Jr, Ordovas JM, McNamara JR, Robbins AM, Meade T, Cohn SD, Salem DN, Wilson PWF, Masharani U, Frossard PM, Schaefer EJ. DNA polymorphisms of the apolipoprotein B gene in patients with premature coronary heart disease. Atherosclerosis 1990; 82: 7-17.
28. Xu CF, Nanjec N, Tikkanen MJ, Huttunen JK, Pietinen P, Butler R, Angelico F, Del Ben M, Mazzarella B, Antonio R et al. Apolipoprotein B amino acid 3611 substitution from arginine to glutamine creates the Ag (h/I) epitope: the polymorphisms is not associated with difference in serum cholesterol and apolipoprotein B levels. Hum Genet 1989; 82: 322-326.
29. Myklebost O, Rogne S, Hjermann I, Olaisen B, Prydz H. Association analysis of lipid levels and apolipoprotein restriction fragment length polymorphisms. Hum Genet 1990; 86: 209-214.
30. Saha N, Tong MC, Tay JSH, Jeyseelan K, Humphries SE. DNA polymorphisms of apolipoprotein B gene in Chinese coronary artery disease patients. Clin Genet 1992; 42: 164-170.
31. Tybjaerg-Hansen A, Nordestgaard BG, Gerdes LU, Humphries SE. Variation of apolipoprotein B gene associated with myocardial infarction and lipoprotein levels in Danes. Atherosclerosis 1990; 89: 69-81.
32. Hosking JL, Bais R, Sobecki SK, Tallis GA, Bradley J, Thomas DW. Lipid parameters and apolipoprotein B RFLP studies: comparison of normal and coronary disease groups as defined by angiography. Clin Biochem 1992; 25: 303-330.
33. Hansen PS, Gerdes LU, Klausen IC, Gregersen N, Faergeman O. Polymorphisms in the apolipoprotein B-100 gene contributes to normal variation in plasma lipids in 464 Danish men born in 1948. Hum Genet 1993; 91: 45-50.
34. Friedewald WT, Levy RI, Frederickson DL. Estimation of the concentration of low-density lipoprotcin cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Clicm 1972; 18: 499-502.
35. Kunkel LM, Smith KD, Boyer SH, Borgaonkar DS, Wachtel SS, Miller OJ, Breg WR, Jones HW Jr, Rary JM. Analysis of human Y-chromosome specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 1977; 74: 1245-1249.
36. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi RG, Horn TT, Mullis KB, Erlich HA. Primer-directed enzymatic amplification of DNA with thermostable DNA polymerase. Science 1988; 239: 487-491.
37. Knott TJ, Rall SC, Innerarity TL Jr, Jacobson SF, Urdea MS, Levy-Wilson B, Powell LM, Pease RJ, Eddy R, Nakai H et al. Human apolipoprotein B: structure of carboxyl-tcrminal domains, sites of gene expression, and chromosomal localization. Science 1985; 230: 37-43.
38. Sokal RR, and Rohlf G. Biometry, 2nd ed. Freeman, San Francisco, CA. 1983.
39. Chakravarti A, Buetow KH, Antonarakis SE, Waber PG, Boehm CD, and Kazazian HH. Nonuniform recombination within the human β-globulin gene cluster. Am J Hum Genet 1984; 36: 1239.
40. Law A, Wallis SC, Powell LM, Pease RJ, Brunt H, Priestly LM, Knott TJ, Scott J, Altman DG, Miller CJ et al. Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet 1986; i: 1301-1303.
41. Talmud P, Barni N, Kessling AM, Carlsson P, Darnfors C, Bjursell G, Galton D, Wynn V, Kirk H, Hayden MR et al. Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: a study in normoand hyperlipidaemic individuals. Atherosclerosis 1987; 67: 81-89.
42. Aburatani H, Matsumoto A, Itoh H, Yamada N, Murase T, Takaku F, Itakura H. A study of DNA polymorphism in the apolipoprotein B gene in a Japanese population. Atherosclerosis 1988; 72: 71-76.
43. Darnfors C, Wiklund O, Nilsson J, Gerard B, Carlson P, Johansson S, Bondjers G, Bjursell G. Lack of correlation between the apolipoprotein B AbaI polymorphism and blood lipid levels in a Swedish population. Atherosclerosis 1989; 75: 183-188.
44. Pan JP, Chiang AN, Jen Tai J, Wang SP, Chang MS. Restriction fragment length polymorphisms of apolipoprotein B gene in a Chinese population with coronary heart disease. Clin Chem 1995; 41: 424-429.
45. Turner RP, Talmud PJ, Visvikis S, Ehnholm C, Tiret L. DNA polymorphisms of the apolipoprotein B gene are associated with altered plasma lipoprotein concentrations but not with perceived risk of cardiovascular disease: European Atherosclerosis Research Study. Atherosclerosis 1995; 116: 221-234.
46. Krul E, Kleinman Y, Konishita M, Pfleger B, Oida K, Law A, Scott J, Pease R, Schonfeld G.. Regional specificities of monoclonal anti-human apolipoprotein B antibodies. J Lipid Res 1988; 29: 937-47.
47. Glišic S, Savic I, Alavantic D. Apolipoprotein B gene DNA polymorphisms (EcoRI and MspI) and serum lipid levels in the Serbian healthy population: interaction of rare alleles and smoking and cholesterol levels. Genetic Epidemiology 1995; 12: 499-508.